Pricing Log in Create free account

Dyne Therapeutics, Inc. (DYN) vs Viking Therapeutics, Inc. (VKTX)

Dyne Therapeutics, Inc. and Viking Therapeutics, Inc. are both Biotechnology companies. Dyne Therapeutics, Inc. and Viking Therapeutics, Inc. are of similar size ($3.3B and $3.2B). Across the 10 metrics below, Dyne Therapeutics, Inc. leads on 7 and Viking Therapeutics, Inc. on 3.

Valuation

Metric DYN VKTX Biotechnology median
P/E n/m n/m 10.26
P/S n/m n/m 9.18
P/B 4.13 5.18 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (19.00%) (20.90%) (34.89%)
Free cash flow yield (16.56%) (15.17%) (24.52%)

Profitability

Metric DYN VKTX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (81.57%) (96.37%) (50.12%)
Return on assets (60.29%) (73.07%) (45.60%)
Return on invested capital (1,956.27%) 0.00% 0.00%

Growth

Metric DYN VKTX Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (2.97%) (215.84%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYN VKTX Biotechnology median
Debt to equity 0.30 0.43 0.00
Current ratio 12.02 7.27 4.89
Net debt to EBITDA 2.05 1.76 1.01

Dividend

Metric DYN VKTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DYN VKTX Biotechnology median
Market cap 3.24b 3.29b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack